start portlet menu bar

Προβολή διαδικτυακού περιεχομένου

Display portlet menu
end portlet menu bar

Experience of the use of HIPRAVIAR® SHS in broiler chickens

Αρχική Γνώση Experience of the use of HIPRAVIAR® SHS in broiler chickens

Experience of the use of HIPRAVIAR® SHS in broiler chickens

aMPV causes an infection in the respiratory tract of chickens and turkeys of any age (Hafez 1993; Cook 2000), resulting in the appearance of clinical symptoms, early in turkeys, and based on various factors in chickens (field pressure, bad management, lack of biosecurity, health problems...).

Κατέβασε αυτό το άρθρο

603 KB

Σχετικά με αυτό το άρθρο

Ημερομηνία

18 Δεκ 2016

Περίληψη

The respiratory problems and the whole symptomatology described above disappeared after the start of vaccination, and the zootechnical results showed an improvement in all areas. The whole comparative study was carried out on the same farm, in successive batches, with a total length of 8 months (4 batches, 2 without vaccination against aMPV and 2 vaccinated). The farm comprises of six shed, with a capacity of 240,000 birds per cycle. A total of 917,000 birds were evaluated.

Σχετικές υπηρεσίες

Υπηρεσία Diagnos

Σχετικά προϊόντα

HIPRAVIAR® SHS

Σχετικές δημοσιεύσεις

Study of the joint administration of HIPRAVIAR® SHS with respiratory vaccines for preventing Newcastle Disease and infectious bronchitis Evaluation of serological response (IgG) following avian Metapneumovirus vaccination and challenge

Μοιραστείτε

start portlet menu bar

Experience of the use of HIPRAVIAR® SHS in broiler chickens

Display portlet menu
end portlet menu bar

Δείτε επίσης

Εκδόσεις

Serological behaviour of an inactivated vaccine against salmonella enteritidis and typhimu...

28-09-2017
Post

Vaccines are not dosed in the same way as antibiotics. This concept is even more relevant ...

13-07-2017
Νέα

Total Control of Coccidiosis in Mexico starts with Smart Vaccination

19-07-2018